BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/13/2026 4:21:12 AM | Browse: 5 | Download: 0
Publication Name World Journal of Diabetes
Manuscript ID 118650
Country China
Category Pharmacology & Pharmacy
Manuscript Type Basic Study
Article Title Tangwang formula ameliorates diabetic retinopathy by inhibiting cell apoptosis and regulating the intestinal microbiota and metabolic profiles
Manuscript Source Unsolicited Manuscript
All Author List He Zhang, Jia-Xin Xing, Yi-Fei Yin, Jun Li, Chen-Xu Jing, Song-Yan Liu, Jin-Zhu Yin, Xiang Gao, Zu-Guo Liang, Tong-Yi Yuan, Hang Su, Ying-Qian Li, Ze-Yu Wang, Hai-Si Dong, Da-Qing Zhao, Da-Shi Ying, Zhen-Wei Zhou and Qing-Xia Huang
Funding Agency and Grant Number
Funding Agency Grant Number
the Noncommunicable Chronic Diseases-National Science and Technology Major Project No. 2023ZD0509300
Science and Technology Development Plan Project of Jilin Province No. 20230402040GH
Jilin Province Undergraduate Innovation Training Program Project No. 202410199024
Medical Center Project of Changchun University of Traditional Chinese Medicine Affiliated Hospital No. DXZX-04-08
Corresponding Author Qing-Xia Huang, MD, Research Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, No. 1478 Gongnong Road, Changchun 130021, Jilin Province, China. hqx19890928@163.com
Key Words Tangwang formula; Diabetic retinopathy; Cell apoptosis; Intestinal bacteria; Metabolic profiles
Core Tip This study identified the main active components of Tangwang formula (TWF) and explored its protective mechanism against diabetic retinopathy mice induced by streptozotocin using network pharmacology, molecular docking, 16S ribosomal RNA sequencing, and metabolomics analysis. Four key active components were identified in TWF that participated in regulating the inflammation and apoptosis. TWF might reduce blood glucose, and alleviate retinal injury by modulating the intestinal microbiota and metabolic homeostasis. These findings provide a theoretical basis for the clinical application of TWF in the treatment of diabetic retinopathy.
Citation Zhang H, Xing JX, Yin YF, Li J, Jing CX, Liu SY, Yin JZ, Gao X, Liang ZG, Yuan TY, Su H, Li YQ, Wang ZY, Dong HS, Zhao DQ, Ying DS, Zhou ZW, Huang QX. Tangwang formula ameliorates diabetic retinopathy by inhibiting cell apoptosis and regulating the intestinal microbiota and metabolic profiles. World J Diabetes 2026; In press
Received
2026-01-08 00:27
Peer-Review Started
2026-01-12 00:27
First Decision by Editorial Office Director
2026-02-26 07:20
Return for Revision
2026-02-26 07:20
Revised
2026-03-10 08:59
Publication Fee Transferred
2026-03-11 02:20
Second Decision by Editor
2026-05-13 02:45
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-05-13 04:21
Articles in Press
2026-05-13 04:21
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com